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With improvements in anesthetic, operative, and
postoperative care, the elective repair of abdominal
aortic aneurysms (AAAs) has become a highly effec-
tive procedure, with most series reporting mortality
rates of less than 5%. However, a similar evolution
has not occurred for the emergency repair of rup-
tured AAAs. Despite advances in care that have
occurred over the last few decades, the mortality rate
for the emergency repair of ruptured AAAs still
remains high at 20% to 70%.1-9 Such dismal results
have prompted many to question whether repairing
ruptured AAAs should even be attempted, particu-
larly in subsets of patients in whom the probability
of a fatal outcome is high.10,11 Prolonged suffering
and pain may precede eventual death. Moreover, the
average cost of repairing ruptured aneurysms is sig-
nificantly higher than that of elective repair because
of the greater use of valuable resources.12,13
The risks associated with repairing ruptured
AAAs have been assessed in multiple studies. In only
a few reports has the cost of the repair been evaluat-
ed, and in these studies, only the costs associated
with the initial hospitalization were deter-
mined.2,3,12-14 A formal cost-effectiveness analysis
has not been performed in which the long-term
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Background: Although advances in technology have reduced the operative risk of elective
abdominal aortic aneurysm (AAA) repair, the surgical repair of ruptured AAAs is asso-
ciated with a much poorer prognosis and a higher cost. Accordingly, it has been sug-
gested that patients with predictably high rates of morbidity and mortality from rup-
tured AAA may not benefit from surgical intervention.
Methods and Results: A cost-effectiveness analysis was performed with the use of a Markov
decision-analytic model to compute long-term survival in quality-adjusted life years and
lifetime costs for a hypothetical cohort of patients with ruptured AAAs managed with
either a strategy of open surgical repair or no intervention. Probability estimates for the
various outcomes were based on a review of the literature. Average costs of (1) the imme-
diate hospitalization ($28,356) and (2) complications resulting from the procedure were
based on the average use of resources as reported in the literature and from a hospital’s
cost accounting system. Our measure of outcome was the incremental cost-effectiveness
ratio. For our base-case analysis, the repair of ruptured AAAs was cost-effective with an
incremental cost-effectiveness ratio of $10,754. (Society is usually willing to pay for inter-
ventions with cost-effectiveness ratios of less than $60,000; for example, the cost-
effectiveness ratios for coronary artery bypass grafting and dialysis are $9500 and
$54,400, respectively.) In sensitivity analyses, the cost-effectiveness of repairing ruptured
AAAs was influenced only by alterations in the operative mortality. If the operative mor-
tality exceeded 88%, repair of ruptured AAAs was no longer cost-effective. As an indepen-
dent variable, increasing age had no substantial impact on the cost-effectiveness, although
it is reported to be associated with increased operative mortality. It was necessary that the
patient’s cost of the initial hospitalization for ruptured AAA exceed $195,000 before
repairing ruptured AAAs was no longer cost-effective.
Conclusions: Our analysis suggests that despite the high cost and poor outcomes, the sur-
gical repair of ruptured AAAs is still cost-effective when compared with no intervention.
The cost of repairing ruptured AAAs falls within society’s acceptable limits and there-
fore should not be a consideration in the management of patients with AAAs. (J Vasc
Surg 2000;32:247-57.)
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costs associated with the surgical repair of ruptured
aneurysms are considered. Only with such a model
can the cost-effectiveness of the surgical repair of
ruptured AAAs be compared with other accepted
medical interventions.
Using the methods of decision analysis, we have
evaluated the cost-effectiveness of the repair of rup-
tured AAAs relative to a strategy of no intervention.
A critical element of decision analysis is the ability
for one to assess both the immediate and the long-
term costs and outcomes related to an intervention.
To this end, we have developed a Markov model that
incorporates all the possible outcomes and costs
associated with the surgical repair of ruptured AAAs.
The objective of this analysis was to determine
whether repairing ruptured AAAs is an appropriate
use of societal resources.
METHODS
The decision-analytic model
We developed a decision-analytic model that
reflected the possible clinical outcomes and costs
associated with a hypothetical cohort of 72-year-
old3,7,8 patients with ruptured AAAs (Fig 1). Patients
underwent either an emergency operation or no
intervention. It was assumed that if a patient received
no intervention for a ruptured AAA, then death
would immediately follow. Operative intervention is
associated with numerous possible outcomes, includ-
ing successful repair, various complications, or death.
These outcomes form the “branches” of a decision
tree. A probability of occurrence and cost is assigned
to each branch. Using a computerized Markov deci-
sion-analytic model (SMLTREE software, version
2.9; James P. Hollenberg, Roslyn, NY), we tracked
and compared all of the possible clinical events and
outcomes. The Markov model allows the hypotheti-
cal cohort to be followed up until all patients have
died.15 End points for this model included long-term
survival in quality-adjusted life years and the lifetime
treatment costs. Our measure of outcome was the
incremental cost-effectiveness ratio, defined as the
cost per quality-adjusted life year gained by surgical-
ly repairing ruptured AAAs. The lower the cost-effec-
tiveness ratio, the more efficiently a medical inter-
vention uses economic resources.
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Fig 1. Simplified Markov decision-analytic model. A hypothetical cohort of 72-year-old patients with
ruptured AAA may either undergo open surgical repair or have no intervention. The outcomes of open
surgical repair may be successful repair, reversible or irreversible complication, or death. The outcome
of no intervention is death. Each member of the cohort is followed up until death. AAA, Abdominal
aortic aneurysm.
In our initial (base-case) analysis, the single best
estimates of probabilities, costs, and quality-
adjustment factors were used. These variables were
systematically varied through a wide plausible range,
and the effect of these variations on the base-case
conclusion was determined. This process is termed
sensitivity analysis. Because most widely accepted
medical interventions have cost-effectiveness ratios
less than $60,000, we considered this value to be the
threshold for our sensitivity analysis.16 All costs were
converted to 1997 US dollars using the medical care
component of the Consumer Price Index for All
Urban Consumers. In accordance with standard
principles of economic analysis, costs and life
expectancies were discounted at 3% per year to
reflect the greater value of current dollars and life
years compared with that of the future.17
Assumptions
Probabilities. After performing a thorough lit-
erature search, we assigned probabilities and ranges
for sensitivity analyses to our model (Table I). The
mortality rate of emergency operation for ruptured
AAAs ranged from 20% to 70%.1-9 In the literature,
the mortality rate for the operative repair of rup-
tured AAAs did not vary with the type of study per-
formed (eg, population based, multicenter, single
institution). For our base-case analysis, we estimated
a probability of death of 50% on the basis of a
weighted average of seven large studies consisting of
a total of 7172 repairs.2-8
For the purpose of this analysis, there were two
types of complications occurring after ruptured AAA
repair: irreversible and reversible. Irreversible compli-
cations in survivors of surgical repair included dialysis-
dependent renal failure, stroke, major amputation, and
myocardial infarction. In assigning the probability to
each of these events, we used a weighted average of
data from studies in which these events were specifi-
cally reported for the cohort of patients. The proba-
bility that a patient would survive a ruptured AAA but
be dependent on dialysis was 3.8%.10,18-21 The proba-
bility of surviving a ruptured AAA repair complicated
by a stroke was assumed to be 1.1%.8,22-26 A value of
0.5% was used as the probability that a patient would
survive ruptured AAA repair complicated by a major
amputation.26-28 The probability that a patient would
survive a myocardial infarction was 2.9%.8,10,18,19
Complications with short-term reversible effects
included graft thrombosis, postoperative hemor-
rhage necessitating laparotomy, and ischemic colitis
necessitating a colectomy. For this analysis, it was
assumed that graft thrombosis would be treated with
surgical thrombectomy. A probability of 3.2% was
assigned to graft thrombosis complicating ruptured
AAA repair.29 The rate of laparotomy for postopera-
tive hemorrhage was assigned a value of 2.3%.1,27,30
The probability of a patient surviving an episode of
ischemic colitis that necessitated a colectomy was
assigned a value of 2.6%.18,24,27,31,32
Costs. For this model, we determined the costs,
not the charges or reimbursements, for the various
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Fig 2. The cost-effectiveness of the surgical repair of ruptured AAAs as a function of the operative
mortality. The dotted line indicates the $60,000 threshold for accepted medical interventions. AAA,
Abdominal aortic aneurysm; QALY, quality-adjusted life year.
interventions and complications. Costs were derived
from the cost accounting system at the New York
Presbyterian Hospital (Transition Systems, Inc,
Boston, Mass) as well as from the literature.
Procedural costs. The major resources consumed
were identified in the calculation of the costs associated
with a ruptured AAA repair, and the costs were esti-
mated according to the average use of these resources
as reported in the literature (Table II). Professional fees
were derived from the Medicare reimbursement for the
appropriate Current Procedural Terminology codes.
It was assumed that both cohorts went to the
emergency department for initial evaluation (cost,
$237). It was assumed that both cohorts underwent
laboratory testing (hemogram, chemistry panel, pro-
thrombin and activated partial prothrombin time, type
and cross; total cost, $70), electrocardiogram ($48),
and chest radiograph ($113) in the emergency depart-
ment as part of the initial examination. The frequency
which computed tomographic (CT) or duplex ultra-
sound (DU) scanning for suspected ruptured AAAs is
obtained varies from 0% to 20%.21,24,33-36 According
to an average of three studies, we assumed that 11.5%
of both operative and nonoperative cohorts would
receive CT scanning of the abdomen for the purposes
of diagnosis.24,34,35 We also assumed that 12.3% of
both cohorts would undergo DU scanning examina-
tion.21,34,36 The time required for the operative repair
of a ruptured AAA (182 minutes) was computed as a
weighted average of seven contemporary studies incor-
porating 1149 operations.18,22,25,28,37-39 We used the
cost of the operating room at our institution, which is
approximately $870 per hour or $14.50 per minute,
to compute total operating room costs. Additional
costs assigned to operative intervention included the
aortic graft ($650), the cell-saving device ($420),40,41
and the transfusion of 10 units of packed red blood
cells ($715),22,36 eight units of platelets ($84), and
two units of fresh frozen plasma ($111). We used 20
days as the average length of hospitalization according
to three studies (10 intensive care unit [ICU] days at
$1500 per day, 10 ward days at $491 per day).5,19,22
Professional fees based on Medicare reimbursement
for the Current Procedural Terminology code for AAA
repair were determined for the surgeon ($2343) and
anesthesiologist ($904). A rate of $74.51 per 15-
minute segment of operation was used to calculate the
latter. Using these estimates, we calculated that the
overall cost for the operative intervention for a rup-
tured AAA was to be $28,356. There have been sev-
eral studies in which the charges (not the costs) asso-
ciated with the surgical repair of ruptured AAAs have
been reported.2,3,11,12 Dardik et al2 reported a hospi-
tal charge of $27,015 for 527 patients who underwent
operative repair of a ruptured AAA in Maryland. The
authors stated that their hospital charge reflected the
cost, but professional reimbursement was not included
in their figure.
Cost of morbidity. Irreversible complications such as
dialysis-dependent renal failure, stroke, major amputa-
tion, and myocardial infarction have both immediate
and long-term associated costs (Table I). We assigned
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Fig 3. The cost-effectiveness of the surgical repair of ruptured AAAs as a function of patient age. The
dotted line indicates the $60,000 threshold for accepted medical interventions. AAA, Abdominal aor-
tic aneurysm; QALY, quality-adjusted life year.
a value of $46,270 to the annual cost of permanent
dialysis.42,43 We estimated a cost of $51,150 for the
first year after a stroke and an annual cost of $26,880
for subsequent years.44 Assuming that 29% of
amputees require long-term nursing care, we estimat-
ed the cost of amputation at $61,570 for the first year
and $39,735 for each subsequent year.45 For myocar-
dial infarction, we estimated a cost of $11,000 for the
first year and $2800 for each year thereafter.46,47
We assigned costs to reinterventions (Table I). We
assumed 120 minutes of operative time for a laparo-
tomy resulting from postoperative hemorrhage and
180 minutes for a colectomy resulting from ischemic
colitis. We assigned a cost of $5710 for the cost of
surgical thrombectomy for graft thrombosis.48
In general, the cost of postoperative complica-
tions that are not associated with long-term sequelae
and are managed in the hospital by medical means
has already been included in the average resource
use derived for patients with ruptured AAA. For
example, patients with postoperative pulmonary fail-
ure will remain in the hospital for an extended peri-
od of time. This and other “in-hospital” complica-
tions produce the excessive ICU and hospital stay
(compared with nonruptured AAA) that we have
already included in our assumptions.
Quality adjustment. A quality-adjustment fac-
tor is assigned to each year that a patient lives with
an irreversible complication according to the quality
of life (Table I). This quality-adjustment factor may
range from 0 (death) to 1 (perfect health). We used
a quality-adjustment factor of 0.68 for patients who
underwent ruptured AAA repair with dialysis-
dependent renal failure.43 Similar adjustments have
also been made for survival with stroke (0.40),44
major amputation (0.80),49 and myocardial infarc-
tion (0.88).50 According to quality-of-life studies,
we assigned a disutility of 52 days for patients under-
going surgical repair of a ruptured AAA, meaning
that 52 days were subtracted from the overall quali-
ty-adjusted life expectancy.12,51,52
Life expectancy. In many studies, researchers have
found that after 30 days, the long-term survival after
either elective or ruptured AAA repair is equiva-
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Table I. Model parameters for the base-case analysis and the ranges tested in sensitivity analysis
Assumptions Base-case Range Reference base-case (range)
Age (y) 72 50-95 3,7,8 (assumed)
Mortality rate 50% 20%-90% 2-8 (1,13)
Probabilities
Irreversible complication
Dialysis-dependent renal failure 3.8% 0.9%-5% 10,18-21 (19,22)
Stroke 1.1% 0%-2.9% 8,22-26 (8,22,23,25,26)
Major amputation 0.5% 0%-1.7% 26-28 (26,27)
Myocardial infarction 2.9% 2%-4.8% 8,10,18,19 (8,18)
Reversible complication
Graft thrombosis, thrombectomy 3.2% 0%-10% 29 (assumed)
Hemorrhage, relaparotomy 2.3% 1.7%-7.2% 1,27,30 (25,27)
Ischemic colitis, colectomy 2.6% 1.4%-4.9% 18,24,27,31,32 (24,32)
Costs 1st year /annually
Initial hospitalization $28,356 $15,000-$200,000 Estimated (12,13)
Irreversible complication
Dialysis-dependent renal failure $46,270/$46,270 $0-$100,000 42,43 (assumed)
Stroke $51,150/$26,880 $0-$100,000 44 (assumed)
Major amputation $61,570/$39,735 $0-$100,000 45 (assumed)
Myocardial infarction $11,000/$2,800 $0-$100,000 46,47 (assumed)
Reversible complication
Graft thrombosis, thrombectomy $5710 $0-$100,000 48 (assumed)
Hemorrhage, relaparotomy $1740 $0-$100,000 Estimated (assumed)
Ischemic colitis, colectomy $2610 $0-$100,000 Estimated (assumed)
Quality adjustment
Dialysis-dependent renal failure 0.68 0-1 43 (assumed)
Stroke 0.40 0-1 44 (assumed)
Major amputation 0.80 0-1 49 (assumed)
Myocardial infarction 0.88 0-1 50 (assumed)
Disutility of operative repair (days) 52 0-356 12,51,52 (assumed)
Discount rate 3% 0%-10% 17 (assumed)
lent.12,21,53 Because the survival in patients undergo-
ing AAA repair is less than the population at large, we
adjusted the US age-specific annual mortality
rates.39,54,55 Using age-specific data from the US
Renal Data System, we adjusted the mortality rate to
account for the reduction in life expectancy resulting
from dialysis-dependent renal failure.56 For 55-, 
65-, 75-, and 85-year-old patients who underwent
dialysis, the excess annual mortality rates were 2.1%,
2.6%, 3.2%, and 3.1%, respectively. We assumed that
patients with a major stroke face an annual excess mor-
tality rate of 7.7%.44 An annual excess mortality rate of
1.5% was assigned to patients with a myocardial infarc-
tion after AAA repair.57 Because most late deaths after
AAA repair are preceded by stroke, dialysis, or myocar-
dial infarction, there is a risk of overestimating the
excess mortality rates associated with these morbidi-
ties. The impact of this overestimation was examined
in sensitivity analyses. Because amputation and graft
thrombosis occurring immediately after AAA repair
are primarily the result of emboli dislodged during the
procedure itself and not inherent peripheral vascular
disease, we assumed that no excess mortality rates
would be assigned to these complications.
RESULTS
Base-case analysis 
For the hypothetical cohort of 72-year-old
patients with ruptured AAAs, operative intervention
provided an average life expectancy of 3.35 quality-
adjusted life years at an additional lifetime cost of
$36,026. This yielded a cost-effectiveness ratio of
$10,754 ($36,026 per 3.35 QALYs) (Table III).
Sensitivity analysis
Baseline assumptions were tested in sensitivity
analyses by substituting a wide range of values for
each variable (Table I). This process allows the
determination of the variables that have the greatest
influence on the outcome of our analysis.
Mortality. We first evaluated the mortality rate
associated with the surgical repair of a ruptured AAA
and its impact on the cost-effectiveness of this inter-
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Table II. Cost breakdown of the initial hospitalization for open surgical repair and no intervention
Open surgical repair ($) No intervention ($)
Initial emergency department evaluation 237 237
Preoperative
Hemogram 6 6
Chemistry panel 17 17
Prothrombin/activated partial prothrombin time 14 14
Type and cross 33 33
Electrocardiogram 48 48
Chest radiograph 113 113
Abdominal CT scan* 94 94
Abdominal DU scan† 18 18
Operative
Operating room time 2,639
Aortic graft 650
Cell-saving device 420
Transfusion of 10 units of packed red blood cells 715
Transfusion of eight units of platelets 84
Transfusion of two units of fresh frozen plasma 111
Surgeon reimbursement 2,343
Anesthesia reimbursement 904
Postoperative
ICU 15,000
Ward 4,910
Total 28,356 580
*CT scanning performed in 11.5% of cohort, at a cost of $818.24,34,35
†DU scanning performed in 12.3% of cohort, at a cost of $150.21,34,36
CT, Computed tomographic; DU, duplex ultrasound; ICU, intensive care unit.
Table III. Base-case analysis
Lifetime Cost-effectiveness
QALYs cost ($) ratio ($/QALY)
No intervention 0 580
Surgical repair 3.35 36,606
Difference 3.35 36,026 10,754
QALY, Quality-adjusted life year.
vention (Fig 2). We used 50% as the base-case mor-
tality rate for ruptured AAA repair. If this mortality
rate was halved to 25%, the cost-effectiveness ratio
diminished from the base-case value of $10,754 to a
value of $6456. If the mortality rate associated with
repair of a ruptured AAA increased to 80%, the cost-
effectiveness ratio increased to $31,008 with an aver-
age extension in life expectancy of 1.15 years versus
the 3.35 years in the base-case analysis. The operation
for ruptured AAA was no longer cost-effective only if
the operative mortality rate increased to a value
greater than 87.7% (ratio > $60,000). With a mortal-
ity rate of 87.7%, the average quality-adjusted life
expectancy of our hypothetical cohort was 7 months.
Morbidity. Varying the rates of the irreversible
complications, such as dialysis-dependent renal fail-
ure, stroke, amputation, and myocardial infarction,
had no effect on the base-case conclusion. If the rate
of dialysis was increased fourfold from 3.8% to
15.2%, the ratio increased to only $18,006. If the
incidence of stroke among survivors of ruptured
AAA increased by a factor of 4% to 4.4%, the ratio
increased insignificantly to $12,907. If the rate of
amputation was increased fourfold to 2%, the cost-
effectiveness ratio increased from $10,754 to
$12,216. If all four morbidities were increased
simultaneously by a factor of four (base-case com-
bined morbidity increased from 8.3% to 33.2%),
repairing ruptured AAAs was still cost-effective with
a ratio of $24,723. Variations in the rates of the
reversible complications, such as graft thrombosis,
postoperative hemorrhage necessitating reoperation,
and ischemic colitis necessitating colectomy, altered
the cost-effectiveness ratio to a lesser degree than
the irreversible complications.
Age. We next evaluated whether alterations in
patient age had an impact on the results of our analysis
(Fig 3). If the age of the patients in the cohort was
reduced from 72 to 50 years, the cost-effectiveness
ratio diminished from $10,754 to $7029. Alternatively,
raising the average patient age to 95 years increased the
ratio to only $38,212. There are many studies in which
it is suggested that operative mortality rates increase
significantly with advancing age. Dardik et al2 found
that for patients younger than 65 years, aged 65 to 69
years, aged 70 to 79 years, and older than 80 years, the
mortality rates were 28.3%, 37%, 51.7%, and 66.7%,
respectively. By simultaneously adjusting the age and
operative mortality, we found cost-effectiveness ratios
for 50- and 95-year-old patients to be $4762 and
$59,460, respectively.
Cost of operation for a ruptured AAA. For
our base-case analysis, we derived an initial hospital-
ization cost of $28,356 for the repair of a ruptured
AAA. When this cost was reduced to $15,000, the
cost-effectiveness ratio diminished to $6766. When
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Table IV. Cost-effectiveness ratios for common medical practices
Medical intervention Cost-effectiveness ratio ($/QALY)*
CEA for symptomatic patients with 70% to 99% ICA stenosis44 4,600
CABG for left main disease59 9,500
Open surgical repair of ruptured AAA 10,754
Hemodialysis for end-stage renal disease60 54,400
CEA for asymptomatic patients with 60% to 99% ICA stenosis44 58,600
Routine cell-saving device for elective AAA repair40 120,800
Orthotopic liver transplantation for hepatocellular carcinoma61 136,900
*All cost-effectiveness ratios adjusted to 1997 US dollars using the consumer price index.
AAA, Abdominal aortic aneurysm; CABG, coronary artery bypass grafting; CEA, carotid endarterectomy; ICA, internal carotid artery;
QALY, quality-adjusted life year.
Table V. Preoperative clinical predictors of operative mortality reported in published series
Preoperative predictor Range of mortality
Systolic blood pressure < 90 mm Hg 28,63,64 42%-84%
Hemoglobin level < 8-9 g/dL10,11,64 59%-94%
Age > 80 y2,11,63 27%-92%
Elevated creatinine level(> 2-3 mg/dL)64-66 71%-86%
History of loss of consciousness19,64,67 77%-100%
Preoperative cardiac arrest11,28,63 67%-100%
Female sex3,11,68 50%-90%
Preexisting chronic obstructive pulmonary disease2,64,65 37%-78%
Preexisting renal disease2,24,69 44%-67%
this cost was increased to $75,000, an operation was
still cost-effective with a ratio of $24,675. Only
when the cost of operation was raised to a value
greater than $195,000 (an improbable scenario) was
the operation for ruptured AAA no longer cost-
effective (ie, cost-effectiveness ratio > $60,000).
Other variables.  It was assumed that the life
expectancy after the emergency repair of ruptured
AAAs is equivalent to that after the elective repair of
nonruptured AAAs.12,21,53 However, Johnston et
al8 reported that for survivors of ruptured AAA
repair, longevity is significantly diminished com-
pared with survivors of elective AAA repair. In sensi-
tivity analyses, if the survival rate of patients after the
repair of a ruptured AAA was decreased by one
third, then the cost-effectiveness ratio increased to
$17,717. Reducing the long-term survival rate by
50% raised the cost-effectiveness ratio to $23,619.
It has recently been suggested that in cost-
effectiveness analyses, age-specific quality adjustment
should be used to account for the higher incidence of
comorbidities in elderly patients.58 Addressing this
issue in sensitivity analysis, we proposed that patients
with ruptured AAA, because of their preexisting
comorbidities, have their quality-adjustment factors
reduced to 85%. We found no substantial change in
the cost-effectiveness ratio for the base-case 65-year-
old patient in our model ($12,640). Alterations in the
excess mortality rates, discount rate, or the cost of
morbidity also did not affect our base-case conclusion.
DISCUSSION
Repair of ruptured AAAs can be costly with the
consumption of valuable medical and societal
resources. Surgeons who treat this condition are
familiar with the not infrequent scenario where a
patient with a ruptured aneurysm survives the initial
procedure, only to die 3 weeks later after a pro-
longed ICU course and the great investment of per-
sonal and financial resources. Because of the finan-
cial burden imposed on society by such patients and
the predictably poor outcomes in certain subgroups
of patients with ruptured AAAs, many have suggest-
ed that a policy of withholding operative interven-
tion may be justified.10,11 Although the high initial
hospital cost of treating patients with ruptured
AAAs has been well documented,2,3,12-14 an analysis
incorporating this cost, the cost of complications,
and the longevity of these patients has not previous-
ly been performed.
We found that despite the high rate of morbidity
and mortality associated with the repair of ruptured
AAAs, operative intervention was cost-effective with
a cost-effectiveness ratio of $10,754. This value is
well within the range of accepted medical interven-
tions (Table IV). Repairing ruptured AAAs has
approximately the same cost-effectiveness ratio as
that of coronary artery bypass grafting for three-ves-
sel disease (cost-effectiveness ratio, $9500).59 Cost-
effectiveness analyses have been previously per-
formed for patients undergoing elective AAA repair.
After incorporating the natural history of aneurysm
growth and the probability of rupture, Katz and
Cronenwett62 concluded that repairing 4-cm AAAs
was cost-effective with a cost-effectiveness ratio of
$21,480 (updated to 1997 US dollars). It appears
more cost-effective to repair ruptured AAAs rather
than to repair elective asymptomatic aneurysms.
From an intuitive standpoint it is difficult to under-
stand why a procedure that is extremely costly and
associated with such an excessive mortality rate is so
highly cost-effective. One must realize, however, that
cost-effectiveness analyses are designed to consider
both the costs and the extension of life provided by an
intervention. The final outcome of a cost-effectiveness
analysis is the cost per quality-adjusted life year saved.
This value is the ratio of two variables: (1) the addi-
tional lifetime costs associated with an intervention
compared with its alternative (in this case, operative
repair vs no intervention), and (2) the extension of life
provided by an intervention compared with its alter-
native. Both variables are critically and equally impor-
tant in the determination of cost-effectiveness. The
cost of the initial hospitalization, as well as the long-
term costs, is high for repairing ruptured aneurysms.
However, the extension of life provided by the repair
of a ruptured AAA is potentially tremendous com-
pared with other medical interventions. For example,
without operative intervention a 70-year-old patient
with a 5-cm asymptomatic aneurysm has only a 20%
chance of dying of aneurysm rupture over the next 5
years, whereas this same patient with a ruptured AAA
has a 100% chance of dying over the next few days.
Clearly, the driving force in the analysis of the cost-
effectiveness of repairing ruptured aneurysms is the
profound extension in life provided by a procedure in
which the alternative is almost certainly death.
The cost of the initial hospitalization for a rup-
tured AAA used in our base-case analysis was
$28,356. This value was determined by estimating
the average use of resources (eg, operating room
time, duration of hospitalization and ICU admission,
blood transfusion) reported in the literature for the
repair of ruptured aneurysms and calculating the costs
of these resources from our hospital’s cost accounting
system. Seiwert et al,14 in a single institution study of
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119 patients, determined an average hospital cost of
$26,110 (updated to 1997 US dollars). Although this
hospital cost does not include professional reimburse-
ments, it closely approximates our estimate for the
hospital cost of repairing a ruptured AAA. This group
also calculated a cost-effectiveness ratio of $4600
(updated to 1997 US dollars) for the repair of rup-
tured AAAs. Although formal decision-analytic tech-
niques were not used in deriving this number, their
finding does support our conclusion that operation
for ruptured AAAs is cost-effective.
In sensitivity analyses, we found only a few vari-
ables that had a significant effect on the base-case
conclusion that operating on ruptured AAAs is cost-
effective. A variable that produced a substantial
effect was the operative mortality. We found that the
repair of ruptured aneurysms was no longer cost-
effective if the mortality rate of surgical repair
exceeded 88%. Thus, if a patient has a greater than
12% chance of survival, then operation should not
be denied on the basis of cost. The average patient
treated for a ruptured AAA needed to survive only 7
months for the procedure to be cost-effective.
We found that age did not significantly have an
impact on the cost-effectiveness of repairing ruptured
AAA. The cost-effectiveness ratio for treating an 80-
year-old patient with a ruptured AAA was $12,138,
which is well within the $60,000 threshold. However,
this finding is based on the assumption that age is an
independent factor that does not influence other vari-
ables in the analysis, such as operative mortality. In
many studies, a greater operative mortality rate has
been observed in elderly patients.3,11,13,38 Dardik et
al2 noted that octogenarians undergoing ruptured
AAA repair had a mortality rate of 67% (not the 50%
used in the base-case analysis). To account for this
relationship between age and operative mortality, we
performed a sensitivity analysis with simultaneous
variations in age and operative mortality. With the
modification of these two variables, our model gener-
ated a cost-effectiveness ratio of $24,141 for an 80-
year-old patient undergoing the repair of a ruptured
AAA. Although this number is higher than the
$12,138 found when age alone is adjusted, the repair
of a ruptured AAA remained cost-effective for all age
groups after simultaneous modification of both the
mortality rate and age. Some investigators have
observed operative mortality rates greater than 90% in
octogenarians.11,13 Under this circumstance, the
combination of age and this exceedingly high opera-
tive mortality has a profound effect on the outcome
of this analysis. For this particular scenario, we deter-
mined a cost-effectiveness ratio exceeding $103,694.
In other sensitivity analyses, the cost of the opera-
tion did not affect our base-case conclusion. The oper-
ative strategy became cost-ineffective only if the cost of
the initial hospitalization was raised to a level above
$195,000. Rohrer et al12 reported an average hospital
cost of $35,500 for the repair of a ruptured AAA with
a range from $15,900 to $156,000. Dean et al13
reported a charge of $84,486 in octogenarians under-
going repair of ruptured AAA. Operative intervention
for ruptured AAAs remains cost-effective, even consid-
ering the wide range of costs/charges reported.
The practical issue that these data raise is whether
therapy for a ruptured AAA should ever be denied. If
we presume a mortality rate of 88% as the threshold
for cost-effectiveness, our analysis raises the question
as to whether a subset of patients who have this oper-
ative mortality rate can be reliably predicted at the
time of their initial presentation. There have been
multiple analyses of the variables that predict a high
mortality rate associated with the repair of a ruptured
AAA. These variables include systolic blood pressure
less than 90 mm Hg, hemoglobin level less than 8 to
9 g/dL, age greater than 80 years, elevated creatinine
level, history of a loss of consciousness, preoperative
cardiac arrest, female sex, and preexisting comorbidi-
ties (Table V). However, no single factor has been
consistently associated with a mortality rate greater
than 88%. Although both preoperative cardiac arrest
and advanced age in many series are associated with
extraordinarily high mortality rates, there are many
other series in which these two variables are associat-
ed with mortality rates of only 60% to 70%.
Combinations of factors will also synergistically
increase mortality.10,64 Halpern et al64 found that
combinations of the following factors were associat-
ed with 100% mortality: loss of consciousness, creati-
nine level greater than 1.5 mg/dL, hemoglobin level
less than 10 g/dL, and systolic blood pressure less
than 90 mm Hg. Hardman et al10 found that three
or more of the following factors predicted a 100%
mortality rate: age greater than 76 years, creatinine
level greater than 1.9 mg/dL, loss of consciousness
after arrival, hemoglobin level less than 9 g/dL, and
electrocardiographic ischemia. Although many possi-
ble risk stratification systems have been proposed,
there is no unanimity, and a method of reliably pre-
dicting mortality that can be universally applied to all
patients who have ruptured AAAs is unavailable.
Thus, if patients with mortality rates greater than
88% cannot be reliably predicted, it becomes difficult
to deny therapy to any patient with a ruptured AAA.
This analysis demonstrates that the surgical treat-
ment of patients with ruptured AAA is an extremely
JOURNAL OF VASCULAR SURGERY
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cost-effective intervention. The increase in survival
versus the alternative of immediate death is the pre-
dominant reason for our finding. Whether therapy
should be denied to any patient who has a ruptured
AAA is debatable. Clearly, our analysis suggests that
this patient should have a uniformly hopeless prog-
nosis before such a decision is made.
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